InvestorsHub Logo
Followers 49
Posts 8357
Boards Moderated 3
Alias Born 02/11/2008

Re: None

Thursday, 07/19/2018 11:17:55 AM

Thursday, July 19, 2018 11:17:55 AM

Post# of 21373
Does Greenvile Health System have nothing left but shares to sell? Prolanta failure?

Seems likely having 900 days in clinical phase 1 trial without a single result, a single provable patient dosed and even a single manufacturer who is currently making PRolanta?

Oncolix could be just a front created to sell shares but the larger culprit could be and needs investigation The Greeneville Health System and the majority stock holder Spence Taylor or Taylor Spence?

If Greenville Health System with years of strategic planning had a shelved product and formed a company around it in order to raise funds, this could be a huge problem. IF GHS used funds to purchase a shell to sell shares, then uplisted the shell in order to sell more shares, what could come next?

A R/S to facilitate another round of Toxic Finance? This time larger? Oncolix Intentions have all been listed in the filings, they have not lied about what they want to do, but no one is reading it?

Obtain shell, raise funds, Increase A/S, raise more funds, Increase A/S, raise more funds?

Oncolix uplistings mean nothing, If Prolanta is still sitting dormat in phase 1? Even if patients were dosed years ago, the life expectancy of what Oncolix was looking for has expired?

This is a horror show and has been from the begining, Micheal Redman, J Donald Payne and the rest of the gang at GreenColix need to step up and explain why Investors have lost of 90% of there Investments since the bogus Merger?

Shame on you GreenColix?

IMO

Everything I post, is In my own opinion, I don't care what you think about it, if you disagree, post it like I do. If you buy or sell stock based on what I say, your a lunatic and should not be trading. Have a great day!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.